Viatris

Update in progress

VTRS (NasdaqGS)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Viatris Inc. is a global healthcare company with operations across North America, Europe, Asia-Pacific and beyond. It has four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. Viatris provides prescription brands, generics, complex generics and biosimilars across cardiovascular, CNS, dermatology, diabetes, oncology, respiratory and more. It also offers patient support, diagnostics, education and digital tools, plus distribution through wholesalers, retailers, mail-order and specialty pharmacies. It collaborates with Mapi Pharma, Revance and Theravance Biopharma. Founded 1961, headquartered in Canonsburg, PA.

Company score

Sentiment: 0.60; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: -0.35; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.31; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.71; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.18; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.21; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive